International firms catch flak in China

Targeting profitable foreign firms operating in China at a time of slowing economic growth seems counterproductive and is a reversal from the past.
September 20, 2015

Biocon opens book for Syngene IPO

Indian pharma company spins off contract research arm, hoping markets will regain a solid footing after Monday's sharp fall.
July 27, 2015

3S Bio raises a healthy $711m via HK IPO

The mainland Chinese biotech firm generated strong demand, with the retail tranche of the offering on the Hong Kong bourse 200-times oversubscribed.
June 07, 2015

Cardinal Health buys Yong Yu from Zuellig

US pharmaceutical distributor Cardinal Health agrees to pay $470 million for China’s largest pharmaceutical importer, Zuellig Pharma China, known locally as Yong Yu.
November 30, 2010